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Abstract
Background: Approximately half of veterans with low-risk prostate cancer receive guideline-discordant imaging.
Our objective was to identify and describe (1) physician knowledge, attitudes, and practices related to the use of
imaging to stage prostate cancer, (2) patient attitudes and behaviors related to use of imaging, and (3) to compare
responses across three VA medical centers (VAMCs).
Methods: A qualitative approach was used to explore patient and provider knowledge and behaviors relating to
the use of imaging. We conducted 39 semi-structured interviews total—including 22 interviews with patients with
newly diagnosed with prostate cancer and 17 interviews with physicians caring for them—between September
2014 and July 2015 at three VAMCs representing a spectrum of inappropriate imaging rates. After core theoretical
concepts were identified, the Theoretical Domains Framework (TDF) was selected to explore linkages between
themes within the dataset and existing domains within the framework. Interviews were audio-recorded, transcribed
verbatim, and then coded and analyzed using Nvivo software.
Results: Themes from patient interviews were categorized within four TDF domains. Patients reported little interest
in staging as compared to disease treatment (goals), and many could not remember if they had imaging at all
(knowledge). Patients tended to trust their doctor to make decisions about appropriate tests (beliefs about
capabilities). Some patients expressed a minor concern for radiation exposure, but anxiety about cancer outcomes
outweighed these fears (emotion). Themes from physician interviews were categorized within five TDF domains. Most
physicians self-reported that they know and trust imaging guidelines (knowledge) yet some were still likely to follow
their own intuition, whether due to clinical suspicion or years of experience (beliefs about capabilities). Additionally,
physicians reported that medico-legal concerns, fear of missing associated diagnoses (beliefs about consequences),
influence from colleagues who image frequently (social influences), and the facility where they practice influences rates
of imaging (environmental context).
Conclusions: Interviews with patients and physicians suggest that physicians are the primary (and in some cases only)
decision-makers regarding staging imaging for prostate cancer. This finding suggests a physician-targeted intervention
may be the most effective strategy to improve guideline-concordant prostate cancer imaging.
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Background
The widespread use of prostate-specific antigen (PSA)
screening has led to prostate cancer stage migration and
changing paradigms of disease management [1, 2]. Con-
temporary patients are unlikely to have advanced disease,
decreasing the clinical utility of diagnostic imaging in their
staging evaluation. Professional societies and policy orga-
nizations have been unanimous in their prostate cancer
imaging guidelines and quality measures: imaging should
be reserved for patients with high-risk disease and low-
risk patients should not undergo imaging [3–9]. For ex-
ample, the National Comprehensive Cancer Network
(NCCN) Guidelines for Prostate Cancer include precise
recommendations for which prostate cancer patients re-
quire advanced imaging prior to treatment [7, 10]. These
patients should have a life expectancy greater than 5 years
or demonstrate symptoms of metastatic disease (e.g., bone
pain, hematuria, weight loss). Pelvic computerized tomog-
raphy (CT) or magnetic resonance imaging (MRI) should
be used for those patients with locally advanced (T3) or
metastatic (T4) cancer or those with clinically localized
(T1–T2) disease should their probability of lymph node
involvement exceed 10 %. Radionuclide bone scan is rec-
ommended only for T1 patients with PSAs greater than
20 ng/mL, T2 patients with PSA greater than 10 ng/mL,
Gleason score greater than 7, locally advanced or meta-
static cancer, or symptoms suggesting bone metastases.
No other patients require staging imaging.
In spite of these clear proscriptive recommendations,
guideline-discordant imaging is common: almost half of
men with low-risk, localized prostate cancer receive
guideline-discordant, unnecessary imaging. Inappropri-
ate prostate cancer imaging was named by the American
Society of Clinical Oncology (ASCO) and the American
Urological Association (AUA) among their top priorities
for Choosing Wisely, a nation-wide initiative to encourage
stewardship of medical resources [11, 12]. Imaging rates
among men with low-risk prostate cancer have been re-
ported to be as high as 19–74 % in a community cohort,
10–48 % in a SEER-Medicare cohort, and 41 % in the Vet-
erans Health Administration (VHA) [13–16]. There is a
simultaneous underuse of imaging among men with high-
risk disease. Men with high-risk cancer from SEER-
Medicare only underwent bone scan 70–75 % of the time
and only 57–58 % underwent CT, for a total rate of 66 %
receiving guideline-concordant, appropriate imaging;
within VHA, only 70 % receive appropriate imaging for
high-risk prostate cancer [15–17]. The patterns of
guideline-discordant imaging in VHA are particularly
surprising given the absence of the types of financial in-
centives driving utilization in the fee-for-service setting
[14]. Retrospective studies have suggested that non-
clinical factors could be creating a barrier to guideline-
concordant imaging in VHA. For example, veterans with
low-risk prostate cancer who were dual users of VHA and
Medicare had higher odds of inappropriate imaging as
compared to those using VHA benefits only, while dual
users with high-risk cancer had similar odds of appropri-
ate imaging. This finding suggests that health system or
insurance status plays a role in the decision to image men
with prostate cancer [18]. Additionally, clinical factors
(i.e., Gleason score, PSA, and clinical stage) are associ-
ated with imaging utilization in guideline-discordant
ways [7, 16, 18–22]. Perhaps because physicians rely on
personal imaging heuristics, rather than on strict in-
terpretation of guidelines, prior quality improvement ef-
forts seeking to eradicate inappropriate imaging also had a
negative effect on appropriate imaging, limiting utilization
of a guideline-indicated procedure [4, 15, 22, 23]. The
causes of these behavioral modifications are perplexing at
least in part because so little is known about the reasons
why physicians and patients utilize or do not utilize im-
aging to stage prostate cancer.
We sought to explore the use of prostate cancer imaging
using a qualitative research approach. Qualitative studies
in this topical area that seek to further understand guide-
line rejection aim to identify barriers and facilitators to
physician/health care provider adherence. Yet, to our
knowledge, there have been no efforts to understand the
practice of prostate cancer imaging using qualitative
methods [24, 25]. Our findings will be of great interest to
patients, physicians, policy makers, and those seeking to
improve the quality of care for men with prostate cancer.
Methods
Design
We conducted semi-structured interviews with both
prostate cancer patients and physicians who treat pa-
tients with prostate cancer at three VA medical centers
(VAMCs). Originally, Grounded Theory was used to
allow for categories to emerge organically during inter-
views. However, after conducting and analyzing several
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physician and patient interviews, the research team ob-
served that the emerging categories clearly aligned with
those domains previously described in the Theoretical
Domains Framework (TDF). We subsequently used
TDF instead of Grounded Theory for the remainder of
the study. TDF, developed by Michie et al. and validated
by others, incorporates a broad spectrum of individual
and organizational theories to study and better under-
stand the motivations and behaviors of both physicians
and patients in a medical setting [26, 27]. TDF consists
of 12 discrete domains, elucidates facilitators and bar-
riers to behaviors, and can act as a framework for fu-
ture interventions [28, 29]. TDF has been successfully
applied to a wide range of clinical topics such as the
appropriateness of diagnostic imaging for spine disor-
ders, perceived barriers to the reporting of adverse drug
events, and the promotion of adherence to guidelines
for suspected viral encephalitis [28, 30, 31]. TDF, a lit-
erature review, and the research team’s previously pub-
lished findings describing guideline-discordant care
informed the interview guides.
Participants
Participants included veterans diagnosed with prostate
cancer within 6 months prior to initial mail contact and
physicians who reported caring for prostate cancer pa-
tients in the preceding 6 months. Three VAMCs were se-
lected based on two criteria: (1) volume of prostate cancer
patients (in order to ensure a sufficient patient sample)
and (2) diversity of their rates of inappropriate and appro-
priate imaging (high, middle and low). We determined a
site specific rate of appropriate and inappropriate prostate
cancer imaging for each VAMC [21]. Sites classified as
high had an average inappropriate imaging rate of 83 %,
sites classified as middle had an average inappropriate im-
aging rate of 35 %, and sites classified as low had an aver-
age inappropriate imaging rate of 17 %. The median
average yearly number of incident prostate cancer patients
at the high sites was 119 (range, 44–380), the middle sites
was 146 (range, 83–444) and at the low sites was 132
(range, 45–307). The goal of including sites across a var-
iety of inappropriate imaging rates was to elicit a range of
opinions on prostate cancer imaging at VHA.
Sampling
Across the three sites, 22 patients and 17 physicians were
interviewed (39 total) between September 2014 and July
2015. A total of 96 patients and 25 physicians were invited
to participate in the semi-structured interviews (23 % of
eligible patients and 68 % of eligible physicians partici-
pated). Among the 22 patients who participated in the in-
terviews, 32 % were from the high site, 32 % from the
middle site, and 36 % from the low site. Sixty-percent of
the 17 physicians interviewed were from the high site,
23 % were from the middle site, and 17 % were from the
low site. Patients with newly diagnosed prostate cancer
were identified through a query of the VHA OncoTrax
data in the VA Informatics and Computing Infrastructure
(VINCI) database (determined with International Classifi-
cation of Diseases, Ninth Revision, Clinical Modification
diagnostic code 185). Patients with a history of prior ma-
lignancy, those aged over 85 years, and those who did not
have data on PSA, clinical stage, or Gleason score were
excluded. The study team contacted all eligible patients
via mail and subsequent follow-up telephone calls; phy-
sicians were invited to participate via email. Patients were
compensated $40 for their participation; per VHA re-
search guidelines, physicians received no compensation
for study participation. All patients were interviewed in-
person by MS and ES. Interviews lasted an average of
31 min (range, 16—53). Physician interviews were ei-
ther conducted in person or over the telephone, lasting
an average of 45 min (range, 24–58) by DM and ES.
Enrollment was concluded after achieving thematic sat-
uration, the point at which the range of ideas has been
elicited and subsequent interviews do not uncover new
information [32].
Data analysis
All interviews were audio-recorded and transcribed verba-
tim. Transcripts were entered into NVivo 8 qualitative
software to facilitate data management and analysis. Three
researchers (DM, ES, CC) independently reviewed tran-
scripts to develop an initial codebook based on the TDF.
MS, a medical anthropologist, provided a critique of the
analysis and examined the coding to ensure a robust and
defensible classification of the data into relevant domains.
Two researchers (DM and ES) independently coded each
transcript, modified the codebooks as themes emerged,
and met to discuss and reconcile discrepancies until a final
coded transcript was agreed upon. Disagreements around
codes, themes, and subthemes were resolved by discussion
among the team members (DM, ES, and CC) and refer-
ence to the original transcripts. There were a total of 34
codes in the physician codebook mapped to 10 TDF do-
mains and 24 codes in the patient codebook mapped to 8
TDF domains. Emerging themes were further organized
and analyzed using descriptive matrix analyses wherein
the range of responses related to each theme was vi-
sually displayed [33]. After coding and analysis of the
interviews, we identified the most applicable TDF do-
mains (Table 1).
Results
Each quote is followed by a designation (H: high rate of
inappropriate imaging, M: middle rate of inappropriate
imaging, L: low rate of inappropriate imaging) indicating
the site at which the interview took place.
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Patients
Characteristics of patients
We interviewed 22 patients from three VAMCs. Eight
patients (36 %) were African American, 12 (56 %) were
white, one (5 %) was Asian, and one patient (5 %) did
not identify his race. The median patient age was 69
(range 52–79). The veterans in our study population
served in all four branches of the US Armed Forces for a
median of 4 years (range 1.5–20). Half of the partici-
pants had undergone imaging to stage their prostate
cancer (Table 2).
Patient findings: Key themes identified within relevant
domains
Key themes emerging from the patient interviews were
categorized within four domains: goals, knowledge, be-
liefs about capabilities, and emotion.
Domain: Goals
Patients were primarily interested in the treatment and
outcomes of their prostate cancer. No patients reported
specifically requesting an imaging evaluation. Patients’
attention was often so focused on treatment that many
did not remember whether they had received imaging at
all. Therefore, it was difficult for the interviewer to elicit
specific responses about imaging because concerns re-
garding treatment and outcomes dominated the inter-
view. Patients did not discuss the association between
imaging results and subsequent choice of treatment.
I just was more concerned about what was going
to happen after surgery and how I was going to
deal with the recovery part of that. [H]
I really didn’t have any [expectations from
my provider] really, you know. Just get me,
you know, healthy, keep me healthy, you know,
tell me what to do. [M]
Domain: Knowledge
Patients demonstrated limited knowledge about imaging,
both as a general subject and regarding how imaging re-
lated to their care. The majority of patients could re-
member neither whether they had imaging tests nor the
names of the tests they received prior to deciding on treat-
ment. Most patients did not know why they had imaging,
but some said that it was “to check if their cancer spread.”
None of the twenty-two patients interviewed had any
knowledge of any prostate cancer imaging guideline nor
did they have any knowledge of the Choosing Wisely
Campaign.
As the patients explained:
I don’t remember what they did. It seems
like they did an x-ray, but I’m not sure… [L]
I just got in there and I had the MRI. And I don’t
even know really what that was for. [H]
Domain: Beliefs about capabilities
Universally, patients stated that they trusted their doctor
to make decisions about their care, especially related to
imaging. Some patients reported curiosity leading them
to investigate prostate cancer management on their own,
but their inquiries primarily related to treatment op-
tions, not imaging. Other patients relied solely on their
physician’s guidance. As one patient described:
I trust my doctor and he said this is the best
course of action, I have that faith in him.
No matter what anybody else tells me I’m going
to do what my doctor told me. [H]
Table 2 Patient demographic information (n = 22)
Age, median (range) 69 (52–79)
Race
White 12 (54.5 %)
Black 8 (36.4 %)
Asian 1 (4.5 %)
Unknown 1 (4.5 %)
PSA, median (range) 7.0 (2.8–37)
Gleason score
≤6 6 (27.3 %)
>6 16 (72.7 %)
Imaging
CT scan 11 (50.0 %)
Bone scan 3 (13.6 %)
No imaging 11 (50.0 %)
Treatment type
Prostatectomy 7 (31.8 %)
Radiotherapy 7 (31.8 %)
Expectant management 6 (27.3 %)
Other 2 (9.1 %)
Table 1 The domains of the Theoretical Domains Framework
most applicable to prostate cancer imaging, as determined
from analysis of semi-structured interviews of patients and
physicians
Relevant physician domains Relevant patient domains
• Knowledge • Knowledge
• Beliefs about consequences • Beliefs about capabilities
• Beliefs about capabilities • Emotion
• Social influences/norms • Goals
• Environmental context and resources
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In addition to online research, many patients indicated
that they consulted with friends or family regarding
treatment, but none had consulted anyone regarding im-
aging specifically. One participant stated that his family
or loved ones “appreciated” that the doctor ordered the
test, but no patient stated that he had asked for imaging
directly.
Domain: Emotion
The patients did not report concern with the process
of imaging, which was commonly described as a rou-
tine part of prostate cancer care, nor the results of
the tests. One patient recalls his emotional and fear-
ful reaction to cancer outweighing any feelings about
imaging.
I was so nervous. They had the big word that started
with a C, that can dilute your memory. I don’t recall,
off the top of my head, being told that I should get
certain type of traditional testing. [H]
A few patients were mildly concerned about radiation
or stated that they try to avoid it, but none described a
sense of unease about exposure to radiation.
Going back to my history, I was guarding
nuclear weapons. I got trained in radiation.
And I try and avoid any kind of, as much
radiation exposure as I can.” [L]
They’re [x-rays] much, much safer now than
they were then. They use just a fraction
of the power. [L]
Physicians
Characteristics of physicians
We interviewed 17 physicians, all urologists practicing
in VHA. The physicians were a median of 11 years out
from completing residency training (range 1–31). Thir-
teen physicians (76%) were board certified in urology,
and a number of them were fellowship-trained in sub-
specialties such as urologic oncology, male infertility
and microsurgery, minimally invasive oncology, renal
physiology, and health services research. The physi-
cians reported seeing a median of 6 (range 2–12) inci-
dent prostate cancer cases per month (Table 3).
Physician findings: Key themes identified within relevant
domains
Key themes emerging from the physician interviews
were categorized within five domains: knowledge, beliefs
about consequences, beliefs about capabilities, social in-
fluences, and environmental context.
Domain: Knowledge
All physicians felt knowledgeable about the existence
of various published prostate cancer imaging guide-
lines, whether those promulgated by the National
Comprehensive Cancer Network (NCCN), the
European Association of Urology (EAU), or the
American Urological Association (AUA), and how to
access them (online, mobile app, or a print out) but
their self-reported knowledge of the guidelines’
specific recommendations varied.
At our VHA myself and most of the other people that
run our clinic have the NCCN guidelines App and
AUA App on our phone. [H]
The average urologist in practice in the United States
is aware the guidelines exist, is generally aware of
what the guidelines say you should do but probably
doesn’t keep up with the down and dirty details of the
guidelines as they evolve. [L]
Additionally, while many physicians stated that they
“believe in and understand the guidelines,” they also ac-
knowledged practicing outside of the guidelines to vary-
ing degrees. The majority of the physicians who imaged
outside of guideline recommendations stated that one
reason for their behavior was their perception of a “gray
area” within the guidelines.
I would say I have – I have firm cutoffs for who
doesn't need imaging and who does need imaging,
but there's a – there's a gray area in between and
Table 3 Demographic information of physicians interviewed
(n = 17)
Median years from residency (range) 11 (1–31)
Gender
Male 1 (6 %)
Female 16 (94 %)
Race
White 11 (65 %)
Black 2 (12 %)
Asian/Pacific Islander 4 (24 %)
Board certified (%) 13 (76 %)
Sample of fellowship areas • Urologic oncology
• Male infertility and microsurgery
• Minimally invasive oncology
• Renal physiology
• Health services research
Median number of incident
prostate cancer cases per montha
6
Range of incident prostate cancer
cases per montha
2–12
aAs reported by the physician
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so the firm cutoff for who doesn't need imaging is
essentially going to be anyone who has low risk
prostate cancer. [H]
Therefore, even if physicians espouse extensive know-
ledge of the current guidelines, they still express uncer-
tainty regarding the appropriateness of imaging within at
least a subset of patients.
Domain: Beliefs about consequences
Many physicians stated that one reason that they per-
form guideline-discordant imaging is to assuage their
own fears of missing a clinically significant, potentially
unrelated diagnosis. The majority of physicians felt the
dose of radiation associated with prostate cancer im-
aging was safe and did not affect their decision. When
physicians did discuss the downsides or harms of over
imaging, it was often regarding the ramifications of inci-
dental findings.
I think they're just worried because they don't want to
miss something. They don't want …to deny the
patient the proper treatment because they missed
something and a year later they found mets
[metastatic disease]. [H]
Usually the concern about metastatic spread often
trumps the concern about radiation. [M]
Um, because what ends up happening with over
imaging is that you find things that aren't really
clinically important. [H]
Many physicians reported that fear of litigation affects
their own imaging practices and an extra, albeit inappro-
priate, test can provide “comfort” (i.e., peace of mind).
On the other hand, some physicians reported that guide-
lines can provide some “comfort” (in the sense of protec-
tion from litigation) in ordering imaging appropriately.
Medical malpractice is alive and well, and I think it
probably impacts decision making more than most
clinicians will admit to. [H]
The idea that, my God, if I miss it I’m going to get
sued. So people try to throw as much imaging as they
can to kind of deflect the level of responsibility from
themselves. [H]
Domain: Beliefs about capabilities
Many physicians vacillated during the interview about
whether they follow the guidelines, their intuition, or their
own personal protocol. While most endorsed a belief in
the guidelines, many physicians felt that experience or
intuition should take precedence over guidelines, espe-
cially when the patient is in the “gray area.” Less time
since completion of residency training was mentioned by
several physicians as an indicator that they would be more
likely to follow guidelines.
Well if there was some clinical factor that or some
clinical suspicion that, you know, the guidelines are
sort of intended to direct us and I mean I think it
would be very, very infrequent that we’d veer from
the guideline based on just my judgment alone. [L]
Over or underutilization of imaging depends on
the provider’s level of training, how far they are
from residency, whether they’re practicing alone,
you know. [L]
Physicians with more experience and more time since
completion of residency training stated that they are
more likely to follow their intuition or rely on their
experience.
I understand the guidelines and I know them but I’m,
I’m going to go against them for this particular reason
and that’s why we go to medical school, to have our
own opinion on certain things.” [H]
“I routinely obtain imaging on all patients who have
been recently diagnosed with prostate cancer.” [H]
While most physicians stated that they would always
image patients if it was indicated in the guidelines, a few
physicians reported that they might forgo even guideline-
recommended imaging if certain patient factors were
present.
I may not do imaging [even when it is guideline
indicated] for extreme elderly patients or patients
that outright refuse any form of treatment. [H]
No, I can’t think of any reason why I wouldn’t
[image when it was guideline indicated] for a
patient with high risk disease. [H]
Domain: Social influences/norms
Most participants in the middle and high imaging hospi-
tals said that they do not have department-wide standards
and their colleagues do not routinely discuss imaging use.
We don’t have a rigid department-wide guideline
for this. That much I can assure you. [H]
On the contrary, some physicians indicated that being a
part of an academic institution, regular discussions with
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their colleagues and a general consensus to practice
guideline-concordant care (in place at the low imaging
hospital) assisted in practicing high quality care and
guideline concordance.
I’ve got the benefit of being here with a large group
of colleagues at a major university, so I have the
luxury of a lot of smart people around me to keep
me up to date but not all urologists at other VHAs
have that [L]
Within all three VHA hospitals, the physicians identi-
fied a colleague in their department who influenced
others’ imaging behaviors whether it was to image more
or to image within the guidelines.
He does our oncology surgery and he wants to see a
CT scan if they go to surgery. [H]
They tend to follow the practice of the supervising
MD and so when you have mid-levels in the clinic
with the particular MD who is ordering the studies
for intermediate and low grade disease we had mid-
levels also doing the same thing so we have had to
deal with that [M]
Domain: Environmental context and resources
All interviewed physicians were affiliated with both an
academic institution and VHA. Many commented on
the differences between practice norms in VHA and
those of their private or university clinics. Physicians
compared VHA to private or ‘outside care’ in several
areas including: differences in the patient population,
quality of imaging equipment, quality of the radiographic
interpretation, and financial incentives for providers
(which are not directly present in VHA).
Yes absolutely yes there is nothing, there is no
motivation here for that [imaging], which is actually
one of the nice things about the VHA. I think that we
can really focus on the guidelines and focus on giving
really stream lined top of the level care based on best
evidence. [M]
I have noticed that there is a … seems to be a
higher rate of positive findings on imaging at
the VHA that are not clinically relevant. And
so I have been dismayed at the quality of our
radiologists. [M]
Additionally, physicians stated that inappropriate im-
aging takes away resources from other important areas
within the department or hospital.
We were getting bone scans on every patient
diagnosed with prostate cancer and that changed
when somebody woke up and said this is not cost
effective. [H]
If you’re doing something because it’s inexpensive
but ineffective it’s still expensive. [H]
Some physicians stated that their patients who are vet-
erans are less assertive, tend to “trust their doctor,” and
therefore are less likely to ask for additional tests than
patients seen in their private practice. VHA physicians
stated that these phenomena make it less likely that
VHA patients will research the extent of their disease,
predictors of treatment outcomes, or imaging options.
They [VHA patients] typically will accept your
answers and defer to you because they have an
innate trust and respect for doctors. [M]
The veterans though as a group I think are less likely
to push for it [imaging], ask for it or be disappointed
if you’re telling them it’s not going to be done. [M]
Domain: Miscellaneous; Construct: Intervention
When asked about a recommendation to improve
guideline-concordant imaging, most physicians enthusias-
tically supported the idea of such an intervention and sug-
gested the creation and implementation of a Computerized
Patient Record System (CPRS) alert or some other elec-
tronic medical record (EMR)-based strategy to automatic-
ally communicate to them when they order guideline-
discordant prostate cancer imaging. CPRS is a centralized
EMR application within VHA that allows physicians to
enter, review, and update patient information [34]. CPRS
is also designed to assist with clinical-decision making
[34]. Many physicians reported that they are accus-
tomed to these types of reminders but warned against
CPRS alert fatigue. Some participants did not explicitly
mention an EMR-based intervention but all recom-
mended education in some capacity as an important
component of a behavioral intervention.
There could be things embedded in CPRS to help
guide the practitioner in making these decisions.
That’s unique to the VHA though because not every
urology practice has access to electronic medical
records that functions like CPRS. [L]
From an intervention standpoint provider
education would seem to me to be the easiest. [L]
Imaging variation across medical centers
There were stark differences in the physician re-
sponses from the three participating VAMCs (Table 4).
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Physicians from the high imaging utilization site tended to
rely more on intuition or professional experience rather
than guidelines, while physicians from the low imaging
utilization site stated that they almost always image within
guidelines except for rare cases or those which fell in the
“gray area;” the middle imaging utilization site fell some-
where in between. The high site identified one colleague
(whose practices nobody challenged) who routinely im-
ages all low-risk patients. The low utilization site’s chief of
urology sits on a quality improvement committee and dis-
cusses guideline adherence with the department regularly.
Physician knowledge of the guidelines varied (most starkly
at the high imaging utilization site) based on their level of
involvement in research, either their own research or
reading research publications (more involvement with re-
search was associated with greater professed understand-
ing of the guidelines). The low imaging utilization site
reported that attending conferences and being affiliated
with an academic institution kept all physicians up to date
on guidelines, while the intermediate imaging utilization
site gave a variety of inconsistent responses. As one phys-
ician noted:
If you go to the VHA or any other provider in the
U.S. with the same diagnosis of prostate cancer, you
may get … totally different imaging. [M]
Discussion
In this theory-based, qualitative exploration of prostate
cancer imaging behavior, we found a disconnect between
the value that physicians place on imaging and the value
that patients place on it. Most patients’ knowledge about
whether or not they had imaging was limited. Patients
tended to trust their doctor to make decisions about im-
aging. Most did not fear exposure to radiation, but a few
stated that they would rather avoid it. It is not surprising
that patients were focused on treatment options and out-
comes, which involve the greatest risk to the patient’s
well-being and offer the promise of prostate cancer cure.
All physicians felt knowledgeable about prostate can-
cer imaging guidelines but many reported imaging
outside of guidelines out of fear of “missing
something clinically significant“ or “fear of litigation.”
Physicians who were further removed from residency train-
ing reported relying on their experience more than on
guidelines, in contrast to physicians who more recently
completed residency training. Additionally, one imaging
avid colleague (a surgeon requiring all of his/her patients
obtain imaging prior to surgery) was described as influen-
cing prostate cancer imaging utilization across an entire
VAMC. All physicians believed that a behavior change inter-
vention was a worthwhile undertaking and suggested a pro-
gram of physician education in some form; many suggested
an EMR-based intervention such as a pop up alert in CPRS.
Our findings suggest that physicians, not prostate cancer
patients, are the primary drivers of prostate cancer imaging
within the VHA.
Our findings are consistent with the existing literature
on barriers and facilitators to guideline adherence in
broader clinical settings outside prostate cancer. The
themes of fear of missed pathology or fear of litigation
have been salient in other qualitative studies. Providers
Table 4 Differences in the three medical centers—illustrated by quotes
Themes Low rates of inappropriate imaging Middle rates of inappropriate imaging High rates of inappropriate imaging
Knowledge of
guidelines
“Obviously everyone does things
differently, but I’m … I take a very
simplistic approach to it. Where I
essentially follow the NCCN Guidelines.”
“I use them sometimes. Guidelines as a
guideline but I tend to be more cautious,
or shall we say more aggressive in terms
of diagnostic testing.”
“I think as clinicians we can’t just
follow a cookbook recipe.”
Intuition vs.
guidelines
“When I look at something, be it a
guideline or an article, I say mm –
here’s absolute proof that getting that
study doesn’t impact the outcome a bit,
that is evidence.”
“So guidelines are just that they guide
your care they don’t prescribe the care
for you.”
“So I may be capturing a little bit
more and exposing a few more




“They’re doing things appropriately here
but at other VA’s I’ve seen anyone with a
diagnosis of prostate cancer will get a,
a kneejerk bone scan and CT scan.”
“We have spoken with this particular
individual [image avid colleague] but
we found that this was his practice
preference and he really wanted to stick
with it although he understood what the
guidelines were.”
“We’re all part of the referral
process to him and so we all
know what he feels is the next




“I think their answers would be very similar
to mine. We all have a very similar practice
pattern since we’re all practicing with the
same university and VA. We try to follow,
you know, guideline concordant care
across all the different types of cancer
we treat.”
“And so we’ve had a number of patients
with Gleason 6 disease and somebody
ordered a bone scan on them and
now we have to figure out what these
questionable areas of uptake mean.
And we spend a lot of time trying to
discuss these findings to figure out
what to do with them.”
“We have a fellowship – a memorial
trained oncology guy and to tell you
the truth, to argue with him [about
imaging practices] is pretty arrogant
or discourteous.”
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have reported that they would rather manage the conse-
quences of guideline-discordant imaging overuse than be
burdened by fear of missing a diagnosis or getting sued
[35–37]. We found that physicians further from resi-
dency training report relying on personal intuition more
so than do recent graduates. Similarly, previous literature
found senior ICU physicians report a preference for rely-
ing on personal experience rather than objective protocols
(which they felt limited their autonomy), while more jun-
ior physicians were more likely to rely on guidelines [36].
Existing qualitative findings also reveal that clinicians in a
primary care setting do not adhere to strictly to published
guidelines, instead adopting heuristics developed from
personal experiences and interactions with colleagues and
patients [38]. Similar to our findings that colleagues influ-
ence prostate cancer imaging behavior, previous literature
in the ICU setting has reported the effects of social pres-
sure on guideline utilization [39].
Using a qualitative approach to understand the barriers
and facilitators to guideline-concordant prostate cancer im-
aging is a critical step to inform design of an intervention
to encourage guideline-concordant behavior. Two prior ef-
forts to implement guideline-concordant prostate cancer
imaging did so without the benefit of such qualitative data
and demonstrated mixed results. The National Prostate
Cancer Register (NPCR) of Sweden [40] established an
audit and feedback program in which national-level data
were used to generate local, hospital-level reports of the
frequency of inappropriate imaging for low-risk prostate
cancer patients. Additionally, the NPCR educated physi-
cians by presenting them with the most recent versions of
imaging guidelines and important literature and stressed
the importance of reducing inappropriate imaging as a
national priority [8]. In another quality improvement inter-
vention, Miller et al. report on a similar strategy employing
audit and feedback combined with physician education im-
plemented within a Michigan State quality improvement
consortium [4, 22]. In both cases, inappropriate imaging of
low-risk patients declined significantly but so did appropri-
ate imaging among high-risk patients [41].
These prior studies reporting quality improvement ef-
forts based on audit and feedback and physician education,
strategies supported by two landmark Cochrane reviews,
might form the basis of an effective multi-level interven-
tion to reduce inappropriate imaging [42, 43]. Our data
additionally suggest physician interest in an EMR-based
decision support tool. In the implementation science lit-
erature, there is strong evidence supporting this interven-
tion strategy, particularly as it relates to advanced imaging
[44, 45]. Computer-based audit and feedback systems
have proven to generate moderate improvements in
guideline adherence among primary care and ICU clini-
cians [39, 46]. However, practical challenges to the fidelity
of such an intervention might limit its effectiveness.
Efforts to implement an EMR-based intervention are likely
to depend upon context and require tailoring to the situ-
ational factors of the implementation setting [47, 48]. The
expression of interest in an EMR-based intervention by
the physicians interviewed in this study suggests optimal
morale for uptake of this strategy.
We found physicians had strong and altruistic, though
sometimes misguided, rationales for performing guideline-
discordant imaging in patients with low-risk disease. Physi-
cians for the most part felt that they always image high-risk
patients. This fraction of high-risk patients not undergoing
imaging might fall within a gray area for physicians who
use personal imaging heuristics, where the physicians
might not deem imaging to be necessary. While data
against imaging overuse clearly demonstrate its low utility
among low-risk patients, data supporting a mandate for
imaging in high-risk patients are less compelling [49–52].
The low-risk category may be variably-defined but would
always include a group of patients with Gleason less than
7, stage T2 or less and PSA less than 10 [10]; this group
represents the overwhelming majority of men with inci-
dent prostate cancer [14]. Imaging in this cohort would be
inappropriate regardless of the guideline a physician might
use to determine the need for imaging, but this gray area
defining high-risk might create confusion over which of
the smaller group of patients with higher-risk features
need imaging. While the gray areas apply to very few pa-
tients, physicians in our study seemed to bring them up
more frequently than might otherwise be expected, per-
haps suggesting that even minor discrepancies between
various versions of imaging guidelines might confuse their
end users and make all guidelines less accessible. There-
fore, an intervention focused solely on reducing imaging
might have decreased the propensity to order imaging for
patients perceived to be in the gray area. Interventions
seeking to decrease inappropriate imaging among low-risk
patients and simultaneously maintain or improve appro-
priate imaging among high-risk patients might focus on
clearly defining patients who need imaging (perhaps by
defining a clear threshold risk/benefit ratio for imaging)
and actively encouraging the practice there [53].
Employing the TDF is an important step to developing
such an intervention because it allows exploration of a
common set of barriers and facilitators across studies
within a theoretical framework. A 2012 study explored the
beliefs of chiropractors about adherence to evidence-
based recommendations for spine radiography for uncom-
plicated back pain. In this study, five domains were identi-
fied as relevant in the beliefs about consequences, beliefs
about capabilities, social professional role and identity, so-
cial influences, and knowledge [28]. Our study confirmed
the importance of all five of these domains and identified
an additional domain, the environmental context. In our
study, physicians reported that the radiologist interpreting
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the image and the quality of the imaging equipment differ
between the VHA and private practice, as do the prefer-
ences of patients. Physicians also stated that VHA patients
differ from private practice patients in terms of knowledge
of or tendency to request imaging.
Some physicians reported that patients “appreciate”
imaging. Providing patient centered care is often a
cornerstone of best practices, especially in VHA [54].
The physician is therefore presented with a dilemma
when a low-risk prostate cancer patient requests im-
aging outside of suggested guidelines. Such an encoun-
ter presents an opportunity for physicians to educate
their patients about best evidence and national guide-
lines (e.g., Choosing Wisely). This discussion may lead
to the patient accepting the guideline recommendation
or continuing to wish for guideline-discordant prac-
tices. While such a choice is, by definition, “guideline-
discordant,” many experts in evidence-based medicine
would still support the decision [55]. In the current
study, patient preferences were not reported to be a key
barrier to guideline-concordant imaging, but in future
situations where patient preferences were driving the
inappropriate testing, a patient educational component
might be considered as part of a behavioral intervention
to reduce guideline-discordant imaging.
Additionally, the NCCN, EUA, and AUA committees
charged with creating and revising imaging guidelines
should consider clarifying how to address these “gray area”
patients mentioned by many physicians. There were many
contradictions, and responses sometimes vacillated within
an individual interview. Several times, physicians would
state that they attempt to follow the guidelines but later
would describe how they image outside of guidelines for
various reasons. There are multiple factors that contribute
to physicians’ decisions to image, and based on the inter-
view questions, different and even contradictory responses
were elicited. An intervention addressing each of the com-
plex factors elicited in this study would make the greatest
impact, one such part of such an intervention might
simplify the discrimination between high and low-risk
patients [29].
Study limitations
This study was designed to generate deeper knowledge
and understanding of patient and physician attitudes and
beliefs in a specific context. Our findings may not be
generalizable to other settings or other populations, des-
pite reaching theoretical saturation [32, 56]. Additionally,
physician knowledge was not explicitly tested so know-
ledge about imaging guidelines was self-reported; neither
physician-specific nor patient-specific imaging behavior
was recorded. However, it was important while developing
rapport between interviewer and study subject, not to ap-
pear to be evaluating the participant’s knowledge. Lastly,
we did not include radiologists, medical oncologists, or ra-
diation oncologists in our interviews. These potential
stakeholders may also have provided important perspec-
tives. However, urologists are most often responsible for
diagnosing patients with prostate cancer because they are
the ones to first evaluate patients with elevated PSA or
symptoms suggestive of prostate cancer and are the ones
subsequently to stage the disease prior to treatment.
Therefore, urologists are most directly responsible for sta-
ging prostate cancer and ordering imaging tests as a part
of that process.
Conclusions
The results of this TDF-based study of barriers and facilita-
tors to guideline-concordant prostate cancer imaging sug-
gest physicians’ attitudes are the primary driver of
utilization. Patients tended to trust their doctor to make de-
cisions about appropriate tests and reported little interest
in disease staging as compared to treatment. This combin-
ation of attitudes and behaviors suggests targeting physi-
cians might be the most effective strategy for improving
guideline-concordant prostate cancer imaging. Using TDF
to classify and analyze qualitative data about this challen-
ging clinical dilemma not only provides a theoretical frame-
work for understanding these barriers and facilitators but
also an algorithm to identify a set of intervention strategies
to address them [29]. Such behavior change strategies
might involve creating EMR-based decision supports, as
well as strategies to address concerns about missed path-
ology and provide protection against litigation for physi-
cians complying with guideline recommendations. Other
interventions such as audit and feedback and academic de-
tailing, which address other domains with complementary
intervention functions, might be bundled with these to
achieve optimal effectiveness, since they have demon-
strated effectiveness in prior quality improvement initia-
tives and have strong theoretical rationales for their use
[16, 29, 41, 53, 57–60]. This study represents the first step
in a theory-based pathway to identify and overcome the
challenges to guideline-concordant prostate cancer im-
aging [25, 29, 41]. These qualitative data and our current
approach to improve the quality of care for men with
prostate cancer may serve as a roadmap to researchers as
they work to improve the quality of cancer care and im-
aging appropriateness in other settings.
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